Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2012 Jan;2(1):9-11.
doi: 10.4103/2231-0770.94804.

Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review

Belal M Firwana  1 , Rim Hasan, Walid Chalhoub, Mazen Ferwana, Jin-Yong Kang, Joshua Aron, Joseph Lieber
Affiliations
Case Reports

Nephrotic syndrome after treatment of Crohn's disease with mesalamine: Case report and literature review

Belal M Firwana et al. Avicenna J Med. 2012 Jan.

Abstract

Inflammatory bowel disease and its various treatments may affect the kidney in several ways. Recently, case reports have been published documenting the development of nephrotic syndrome after the treatment for inflammatory bowel disease with 5-aminosalicylic acid derivatives. We report a 50-year-old patient who was diagnosed with Crohn's disease and was treated with mesalamine. The patient subsequently developed nephrotic syndrome and a renal biopsy showed minimal change disease. He was treated with losartan and rosuvastatin and showed improvement in his renal function and serum cholesterol level. This is the first reported case in Crohn's disease although there have been six previous case reports of nephrotic syndrome following salicylic acid derivatives for ulcerative colitis.

Keywords: Aminosalicylic acid; Crohn's disease; inflammatory bowel disease; mesalamine; minimal change disease; nephrotic syndrome.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: None declared.

References

    1. Molnar T, Farkas K, Nagy F, Ivanyi B, Wittmann T. Sulfasalazine-induced nephrotic syndrome in a patient with ulcerative colitis. Inflamm Bowel Dis. 2010;16:552–3. - PubMed
    1. Fofi C, Nicoletti MC, Onetti Muda A, Giulio S. [Focal segmental glomerulosclerosis with IgA deposits in a patient with ulcerative colitis] G Ital Nefrol. 2003;20:641–4. - PubMed
    1. Skhiri H, Knebelmann B, Martin-Lefevre L, Grunfeld JP. Nephrotic syndrome associated with inflammatory bowel disease treated by mesalazine. Nephron. 1998;79:236. - PubMed
    1. Fornaciari G, Maccari S, Borgatti PP, Rustichelli R, Amelio N, Lattuada I, et al. Nephrotic syndrome from 5-ASA for ulcerative colitis? Complicated by carcinoma of the colon and sclerosing cholangitis. J Clin Gastroenterol. 1997;24:37–9. - PubMed
    1. Barbour VM, Williams PF. Nephrotic syndrome associated with sulphasalazine. BMJ. 1990;301:818. - PMC - PubMed

Publication types